oxazolidin-2-one has been researched along with Coronary Artery Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhlaghi, F; Mohammadpour, AH | 1 |
| Böhm, M; Laufs, U; Pöss, J | 1 |
| Galbut, BH; Galbut, EJ; Kavinsky, CJ; McMullan, PW; Pacheco-Coronado, R; Schaer, GL; Snell, J | 1 |
2 review(s) available for oxazolidin-2-one and Coronary Artery Disease
| Article | Year |
|---|---|
[HDL and CETP in atherogenesis].
Topics: Amides; Anticholesteremic Agents; Atherosclerosis; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Clofibric Acid; Coronary Artery Disease; Esters; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Nicotinic Acids; Oxazolidinones; Quinolines; Randomized Controlled Trials as Topic; Sulfhydryl Compounds; Treatment Outcome | 2010 |
Myocardial infarction after taking zolmitriptan.
Topics: Aged; Coronary Artery Disease; Female; Humans; Migraine Disorders; Myocardial Infarction; Oxazolidinones; Serotonin Receptor Agonists; Tryptamines | 2005 |
1 other study(ies) available for oxazolidin-2-one and Coronary Artery Disease
| Article | Year |
|---|---|
Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
Topics: Amides; Animals; Anticholesteremic Agents; Benzodiazepines; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Coronary Artery Disease; Esters; Humans; Oxazolidinones; Quinolines; Sulfhydryl Compounds | 2013 |